LSE:HLN (Haleon plc)

About HLN

Haleon PLC is a consumer healthcare company that provides personal healthcare products. The group conducts business internationally across five consumer healthcare categories: Oral Health, Pain Relief, VMS, Respiratory Health and Digestive Health and Other. Its reportable and geographical segments include North America; Europe, Middle East, Africa and Latin America (EMEA and LatAm) and Asia Pacific (APAC). It generates maximum revenue from EMEA and LatAm segments.
  • Haleon plc (LSE: HLN) Latest News

    Chalkboard representation of risk versus reward on a pair of scales
    Investing Articles

    Looking for FTSE shares to buy? Here are 2 to consider for long-term gains

    This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market…

    Read more »

    Number three written on white chat bubble on blue background
    Investing Articles

    Just released: the 3 best growth-focused stocks to consider buying in January [PREMIUM PICKS]

    Highlighting some of our past recommendations we think are of particular interest today, due to a combination of business performance…

    Read more »

    Investing Articles

    The Haleon share price has woken up. Should I buy the FTSE 100 stock now?

    FTSE 100 stock Haleon has shot up over the last month. Edward Sheldon is wondering if it could be a…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Haleon’s share price leaps 3% as first-half results reveal 11% profit increase. Is it time I buy?

    The share price of lesser-known GSK offshoot Haleon is up today after the company's H1 2024 earnings results. I'm considering…

    Read more »

    Young black colleagues high-fiving each other at work
    Investing Articles

    Here’s why the Haleon share price jumped 6% higher today

    As the Haleon share price rises, our writer considers whether he should add this consumer healthcare stock to his portfolio.

    Read more »

    Middle-aged black male working at home desk
    Investing Articles

    Here are some of the best dividend forecasts I’ve seen for 2024

    Jon Smith talks through two income stocks that have attractive dividend forecasts for the coming year, thanks to a strong…

    Read more »

    Shot of a young Black woman doing some paperwork in a modern office
    Investing Articles

    The Haleon share price is stuck at £3! Should I invest?

    The Haleon share price hasn't moved much since last summer. Could this be a good opportunity for me to invest…

    Read more »

    Investor looking at stock graph on a tablet with their finger hovering over the Buy button
    Investing Articles

    Should investors buy Haleon shares after the company raised its full-year guidance?

    Haleon shares could be worth a look after today’s H1 results, says Edward Sheldon. But there are a few risks…

    Read more »

    Asian man looking concerned while studying paperwork at his desk in an office
    Investing Articles

    Are Haleon shares a ‘buy’ ahead of tomorrow’s earnings?

    Haleon shares are almost flat since they launched just over a year ago. But there could be some movement on…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    If I’d put £1,000 in Haleon shares 1 year ago, here’s what I’d have now!

    Haleon shares are one of the newest additions to the FTSE 100. Here, Dr James Fox takes a closer look…

    Read more »

    Frustrated young white male looking disconsolate while sat on his sofa holding a beer
    Investing Articles

    Are Haleon shares a long-term bargain?

    Haleon shares are just 2% higher than when they listed nearly a year ago. Does that present a possible bargain…

    Read more »

    Young Black woman looking concerned while in front of her laptop
    Investing Articles

    If I’d invested £1,000 in the Haleon shares spin-off, here’s how much I’d have now

    Haleon shares have been public for almost a year but investors remain hawkish over looming legal risks. Zaven Boyrazian investigates…

    Read more »